viernes, 4 de septiembre de 2026

The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains The paperwork was never really the problem with clozapine

https://www.statnews.com/2026/09/04/clozapine-children-schizophrenia-neutrophil-fda-monitoring/ By Nitin GogtaySept. 4, 2026 Gogtay is a psychiatrist, physician-scientist, and author of “The Vanishing Children: A Psychiatrist’s Journey to Unravel the Mysteries of Childhood Psychosis.”

No hay comentarios: